@KirkShares So the CEOs has last week confirmed no placing on the horizon. Formally.
But Kirk from Corrie says otherwise!
Don’t be that guy Kirk. Get stuck in with your short, each to their own, but don’t lie. Lying and misinformation is a nasty little game. You’re better than that #HEMO
#HEMO new lab premises. Bigger and better. The team is expanding.
A serious company pursuing serious commerciality needs a serious base.
Hurtling towards super stardom. Buy, hold, sit back and let HEMO do all the hard work.
It’s about prospective value. For example if it’s a $2b end game, what’s that equate to now? Currently valued at £20m is frankly crackers. My view is more like somewhere around £75m at this stage (7.5pish) based on peer valuations. #HEMO
Serious upside short and long term.
Well, all eyes on #HEMO this morning…
…kills the rumours off from the start, straight from the Horse’s mouth : NO PLACING
So how far do @HemogenyxPharma rally today?!
Fastest on the trigger wins…
https://t.co/Z1GMnSamOe
People need to understand the significance of wholly taking ownership of a billion dollar asset for literally peanuts. One of two billion dollar assets! #HEMO
No placings in the foreseeable!!
Well. What a day! It’s fair to say the SP hasn’t quite reacted as many hoped and it remains clearly far detached from the sort of MCap I believe #hemo is worthy of.
Let’s see if the market starts to recognise the quality of Hemo in the next few sessions. More news plz.
#onwards
#HEMO
Initially caught by the 8 30 am RNS the MMS quickly dropped the SP after the surge to 3pish and now do not want to let it go ... PEEL HUNT are controlling.
Someone wants in to the stock with a big order around 2.5p
Technicals are superb
It will bounce up.
@Fox_in_the_hole@KirkShares@AndrewPokerLife I’m happy with their financial position currently and understand moving to IND app status opens additional funding doors. They’ve recruited excellently so have an expert negotiator to secure further non dilutive funding. Exciting times coming up. #HEMO
I like this! And I don’t think you’re far off the mark
Multiple applications if he drug that will be desirable by different companies who focus in such areas
#HEMO
2/2 this whole collab massively validates the quality of #HEMO tech as they’ve got big pharma working with them. Peaking over their shoulder. Steering them in the right direction til the time is right.
And it’s just one of a multi product portfolio. The market will come round.
After working on CDX for over three years with #HEMO do they like/want the drug? You bet they love it and know good it is potentially!
If early trial indications are it’s safe and works will they
A) not buy it
B) buy it
This is just the pre-dance to the big dance 😉
1/2
#HEMO finally get the licensing arrangement over the line. Eli Lilly, who’d have guessed they were GlobalCo?!?! 😂 BIG BIG PHARMA!
With this deal now sorted the company can focus on driving it’s multiple projects forward. Let the news flow commence and the proper rerate begin
@AndrewPokerLife Ultimately replacing chemotherapy. That restricts many younger and older sufferers from even pursuing treatment as it is so toxic.
Absolute game changer is #HEMO. It’s time is coming. Somewhat slower than I’d have liked with a number of large speed bumps thrown in. #milestones
#HEMO has had plenty of sharp significant drops over the last 6m and it’s been v painful. Finally today we c a sharp little rise and high volume. I expect many more rises shorter term from now, into the end of the year and then long term next year as well.
#TrustTheProcess
There’s a huge disparity between how I’m feeling about #HEMO (excited) and the upcoming news flow and the SPs view of it all (zero hype).
Imminent Clinical trials simply not priced in. Half market cap is in cash with multiple patents & cutting edge R&D tech valued at nada 🤷♂️